Our Latest
Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
Clinical Trial Finds Artificial Intelligence-Guided Procedure for Persistent Atrial Fibrillation Superior to Current Standard of Care
iVEAcare Launches with $27.5 Million in Series A Funding from Leading Medtech Investors
Elucent Medical Secures Series C Funding to Advance Oncologic Surgery Innovation
Trinity Capital Inc. Provides $25 Million Growth Capital To Moxe Health
Vensana Capital Strengthens Team with Promotions and Addition of Venture Partner
January 3, 2024 MINNEAPOLIS & WASHINGTON, DC—(BUSINESS WIRE)—Vensana Capital, a leading medical technology-focused venture capital and growth equity investment firm, today announced the promotions of Amrinder Singh, Cynthia Yee, Greg Banker, and Mike Kramer to Partner and Steve Schwen to Partner & Chief Financial Officer. The firm also announced the addition of veteran medtech leader […]
Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.
Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Vascular Imaging Platform
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
SpyGlass Pharma Completes $90 Million Series C Financing to Advance Novel Treatments for Glaucoma and other Chronic Ophthalmic Diseases
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial
Curate Biosciences launches its first product to transform cell therapy manufacturing costs and performance
Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation
Curate Biosciences Announces David Backer as Chief Executive Officer
Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology
Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery
Nov 8, 2022 MINNEAPOLIS – November 8, 2022 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the International Society for the Advancement of Spine Surgery (ISASS) has published an updated Policy Statement and Literature Review of Intraosseous Basivertebral Nerve […]
Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million
Moxe Health Raises $30M Series B to Further Advance Interoperability
Relievant: Just Clear, Rigorous High-Quality Data
Results from Multiple Clinical Trials Demonstrate the Intracept Procedure is: Safe Strong safety profile with less than 0.3% rate of serious Intracept Procedure-related complications reported across nearly 400 clinical trial patients. 1 Effective Two Level I RCTs demonstrate that the Intracept Procedure is an effective treatment compared to both a sham-control procedure and to non-surgical standard […]
CLARIFY 2 Affirms Cleerly Over Invasive Heart Disease Evaluation Methods
February 14, 2022 Findings from Cleerly’s groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease evaluation. Instead of proactively identifying patients at risk of heart disease, our industry has historically treated patients once symptoms appear, which can result in late or missed diagnoses, as well as […]
Envisioning a World Without Heart Attacks: A Call For A New Paradigm of Precision Heart Care
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: January 28, 2022 Historically, our diagnostic approaches to patients with suspected heart disease have been restricted to the evaluation of patients with symptoms like chest pain and shortness of breath. Yet, these diagnostic methods fail for the >50% of individuals who will suffer […]
Relievant: When there’s a clear, documented way to diagnose vertebrogenic pain. That’s Living Proof.
The Background To confirm that a patient has vertebrogenic pain, physicians use MRI to look for specific changes that occur with endplate inflammation, which are called Modic changes. They’re called “Modic changes” because in 1988, Dr. Michael Modic was the first to publish on identifying and classifying degenerative endplate and marrow changes surrounding a dehydrated […]
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics
Apella Announces $21 Million Series A Funding to Digitize the Operating Room
Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical
Vensana Capital Raises $325 Million and Expands Team to Back Transformative Medical Technology Innovations
September 27, 2021 MINNEAPOLIS & WASHINGTON, DC—(BUSINESS WIRE)—Vensana Capital today announced the closing of its second fund, Vensana Capital II, with $325 million in committed capital. The fund was oversubscribed at its hard cap with the support of the firm’s investors in its inaugural fund alongside select new institutional investors. Vensana Capital launched in 2019 […]
Vensana’s Kirk Nielsen to Co-Chair the 2021 Medtech Venture & Partnering Conference in Minneapolis
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
This AI Startup Raised $43 Million To Save Lives (And Money) By Treating Heart Disease Earlier
Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease
GPB Scientific Announces Additional Growth Financing to Support Commercialization of Curate™ Cell Processing System for Next-Generation Cell & Gene Therapies
Vensana Capital Founders Offer Public Comments in Support of CMS Final Rule, “Medicare Program; Medicare Coverage of Innovative Technology (MCIT)”
Vensana Capital, a medical technology-focused venture capital firm based in Minneapolis and Washington, DC, is submitting this letter in response to the interim final rule delaying the effective date and requesting additional comment on the final rule establishing the MCIT coverage pathway for Food and Drug Administration (FDA)- designated breakthrough medical devices (“Notice of Delay”).1 […]
NVCA VC Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen
VC Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen MARCH 30, 2021/BY DEVIN MILLER Welcome to our VC Policy Pulse series, where we speak with VC investors on policy issues that are having a major impact on the VC and startup ecosystem. Today, we’re hearing from Justin Klein and Kirk Nielsen, […]
NVCA Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen
Personal Genome Diagnostics Announces Close of $103 Million Series C Financing
Webinar: How Medtech Can Sustain Its Momentum in 2021: Strategies for Successful Investment, Co-Moderated by Justin Klein
SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular
CVRx® Raises $50 Million in New Equity Financing
Klein to speak at Life Sciences Future – MedTech
Eight VCs Join NVCA Board and Barry Eggers of Lightspeed Appointed Chair
GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures
Vensana—Is Medtech Investing on the Rebound?
Medtech investor duo seeks to ‘fill the gap’ in device sector private funding
New Minnesota-based fund has $225 million to invest in young med-tech companies
New med-tech investment firm Vensana Capital launches $225 million fund
Minneapolis-based Vensana Unveils $225 Million Venture Capital Fund
Co-founded by Versant, NEA investors, new medtech VC firm kicks off inaugural fund with $225M bounty
New Medtech Investor Vensana Closes $225 Million Debut Fund
Vensana Capital Launches with Inaugural $225 Million Fund
Podcast: Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana
Kirk Nielsen featured at MedTech Strategist Medical Alley Innovation Summit 2019
Vensana Capital Co-Organizes 26th Annual Phoenix Conference
TEDCO to Host Entrepreneur Expo on October 29 – Vensana Capital’s Justin Klein and AllegisCyber’s Bob Ackerman morning keynotes at the Expo
TEDCO’s annual Entrepreneur Expo was established to spotlight entrepreneurship in the region by bringing together Maryland’s various resources for a day of celebration.